Literature DB >> 2251906

Microglia in cerebellar plaques in Alzheimer's disease.

L A Mattiace1, P Davies, S H Yen, D W Dickson.   

Abstract

Cerebellar amyloid deposits in Alzheimer's disease were studied by immunocytochemistry and with a series of antibodies that recognize human microglia, including anti-HLA-DR, LN-1, Leu-M5 and leukocyte common antigen. Microglia formed a dense reticular array throughout the cerebellum in areas with and without amyloid deposits. In areas with compact and reticular amyloid deposits, microglia had morphological features consistent with activation, such as cytoplasmic swelling and shortening and thickening of cell processes. In areas with diffuse amyloid deposits, microglia had delicate and highly ramified processes. Nevertheless, microglial cells or their processes were detected in association with amyloid deposits of all morphological types. These results raise the possibility that microglia may play a fundamental role in the pathogenesis of amyloid deposition in the cerebellum in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2251906     DOI: 10.1007/bf00294609

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  43 in total

1.  Astrocytes and microglia in human brain share an epitope recognized by a B-lymphocyte-specific monoclonal antibody (LN-1).

Authors:  D W Dickson; L A Mattiace
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

2.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Harigaya
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity.

Authors:  N Kitaguchi; Y Takahashi; Y Tokushima; S Shiojiri; H Ito
Journal:  Nature       Date:  1988-02-11       Impact factor: 49.962

Review 4.  Functional plasticity of microglia: a review.

Authors:  W J Streit; M B Graeber; G W Kreutzberg
Journal:  Glia       Date:  1988       Impact factor: 7.452

5.  Modified Bielschowsky and immunocytochemical studies on cerebellar plaques in Alzheimer's disease.

Authors:  T Suenaga; A Hirano; J F Llena; H Ksiezak-Reding; S H Yen; D W Dickson
Journal:  J Neuropathol Exp Neurol       Date:  1990-01       Impact factor: 3.685

6.  A special type of senile plaque, possibly an initial stage.

Authors:  A Probst; H Brunnschweiler; C Lautenschlager; J Ulrich
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

7.  Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

Authors:  D W Dickson; J Farlo; P Davies; H Crystal; P Fuld; S H Yen
Journal:  Am J Pathol       Date:  1988-07       Impact factor: 4.307

8.  A new immunoperoxidase marker for microglia in paraffin section.

Authors:  J M Miles; S M Chou
Journal:  J Neuropathol Exp Neurol       Date:  1988-11       Impact factor: 3.685

9.  Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques.

Authors:  D W Dickson; H Crystal; L A Mattiace; Y Kress; A Schwagerl; H Ksiezak-Reding; P Davies; S H Yen
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

10.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease.

Authors:  P L McGeer; S Itagaki; E G McGeer
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more
  33 in total

1.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

2.  Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils.

Authors:  J Frackowiak; H M Wisniewski; J Wegiel; G S Merz; K Iqbal; K C Wang
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Deposition of beta/A4 protein along neuronal plasma membranes in diffuse senile plaques.

Authors:  A Probst; D Langui; S Ipsen; N Robakis; J Ulrich
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 4.  Amylin and its G-protein-coupled receptor: A probable pathological process and drug target for Alzheimer's disease.

Authors:  Wei Qiao Qiu
Journal:  Neuroscience       Date:  2017-05-19       Impact factor: 3.590

5.  Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.

Authors:  Alberto Serrano-Pozo; Jing Qian; Alona Muzikansky; Sarah E Monsell; Thomas J Montine; Matthew P Frosch; Rebecca A Betensky; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2016-04-22       Impact factor: 3.685

6.  Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.

Authors:  Elizabeth E Spangenberg; Rafael J Lee; Allison R Najafi; Rachel A Rice; Monica R P Elmore; Mathew Blurton-Jones; Brian L West; Kim N Green
Journal:  Brain       Date:  2016-02-26       Impact factor: 13.501

7.  Cerebellum Can Serve As a Pseudo-Reference Region in Alzheimer Disease to Detect Neuroinflammation Measured with PET Radioligand Binding to Translocator Protein.

Authors:  Chul Hyoung Lyoo; Masamichi Ikawa; Jeih-San Liow; Sami S Zoghbi; Cheryl L Morse; Victor W Pike; Masahiro Fujita; Robert B Innis; William Charles Kreisl
Journal:  J Nucl Med       Date:  2015-03-12       Impact factor: 10.057

8.  Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Sträussler-Scheinker syndrome.

Authors:  M Barcikowska; P P Liberski; J W Boellaard; P Brown; D C Gajdusek; H Budka
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

9.  Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.

Authors:  Maria Manczak; Peizhong Mao; Kazuhiro Nakamura; Christopher Bebbington; Byung Park; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2009-07-19       Impact factor: 6.150

10.  MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.

Authors:  Bin Liu; Jeffrey L Frost; Jing Sun; Hongjun Fu; Stephen Grimes; Peter Blackburn; Cynthia A Lemere
Journal:  J Neurosci       Date:  2013-04-17       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.